PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection

M. Fonseca; G. Tannus; E. Parisi

doi:10.1016/j.jval.2012.03.751

PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection

Value in Health ◽

10.1016/j.jval.2012.03.751 ◽

2012 ◽

Vol 15 (4) ◽

pp. A139

Author(s):

M. Fonseca ◽

G. Tannus ◽

E. Parisi

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype I ◽

Chronic Hepatitis C Virus ◽

Peginterferon Alfa

Download Full-text

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection

Value in Health ◽

10.1016/j.jval.2012.08.770 ◽

2012 ◽

Vol 15 (7) ◽

pp. A329

Author(s):

M. Fonseca ◽

V. Garran ◽

G.T. Araujo

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype I ◽

Chronic Hepatitis C Virus ◽

Peginterferon Alfa

Download Full-text

Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China

Clinical Drug Investigation ◽

10.1007/s40261-018-0702-9 ◽

2018 ◽

Vol 38 (11) ◽

pp. 1031-1039 ◽

Cited By ~ 6

Author(s):

Pingyu Chen ◽

Aixia Ma ◽

Qiang Liu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Virus

Download Full-text

Cost Effectiveness of Daclatasvir Plus Asunaprevir Therapy for Chinese Patients with Chronic Hepatitis C Virus Genotype 1b

Clinical Drug Investigation ◽

10.1007/s40261-018-0621-9 ◽

2018 ◽

Vol 38 (5) ◽

pp. 427-437 ◽

Cited By ~ 10

Author(s):

Yuchen Liu ◽

Zhenhua Wang ◽

Ruoyan Gai Tobe ◽

Houwen Lin ◽

Bin Wu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Chinese Patients ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12871 ◽

2014 ◽

Vol 40 (6) ◽

pp. 657-675 ◽

Cited By ~ 50

Author(s):

S. Saab ◽

S. C. Gordon ◽

H. Park ◽

M. Sulkowski ◽

A. Ahmed ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Portugal

Applied Health Economics and Health Policy ◽

10.1007/s40258-012-0007-8 ◽

2013 ◽

Vol 11 (1) ◽

pp. 65-78 ◽

Cited By ~ 28

Author(s):

Elamin H. Elbasha ◽

Jagpreet Chhatwal ◽

Shannon A. Ferrante ◽

Antoine C. El Khoury ◽

Pedro A. Laires

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

Cost-effectiveness of direct-acting antiviral regimen ombitasvir/paritaprevir/ritonavir in treatment-naïve and treatment-experienced patients infected with chronic hepatitis C virus genotype 1b in Japan

Journal of Medical Economics ◽

10.1080/13696998.2016.1206908 ◽

2016 ◽

Vol 19 (12) ◽

pp. 1144-1156 ◽

Cited By ~ 10

Author(s):

Suchin Virabhak ◽

Kikuo Yasui ◽

Kiyotaka Yamazaki ◽

Scott Johnson ◽

Dominic Mitchell ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virus Genotype ◽

Direct Acting Antiviral ◽

Chronic Hepatitis C Virus ◽

Treatment Naïve ◽

Direct Acting

Download Full-text

Cost-Effectiveness Analysis of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin Regimen for Patients Infected With Chronic Hepatitis C Virus Genotype 1 in Malaysia

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.09.005 ◽

2020 ◽

Vol 21 ◽

pp. 164-171

Author(s):

Asrul Akmal Shafie ◽

Muhammad Radzi Abu Hassan ◽

Siew Chin Ong ◽

Suchin Virabhak ◽

Yuri Sanchez Gonzalez

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Cost Effectiveness Analysis ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

PIN29 Cost Effectiveness Analysis of Addition of Telaprevir or Boceprevir to Standard Therapy Versus Standard Therapy Alone for the Treatment of Previously Untreated Chronic Hepatitis-C Virus Genotype 1 Infection

Value in Health ◽

10.1016/j.jval.2012.03.1305 ◽

2012 ◽

Vol 15 (4) ◽

pp. A242 ◽

Cited By ~ 1

Author(s):

S. Ramachandran ◽

R. Mahabaleshwarkar ◽

Y. Yang

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Standard Therapy ◽

Genotype 1 ◽

Virus Genotype ◽

Effectiveness Analysis ◽

Chronic Hepatitis C Virus

Download Full-text

757 OUTCOME OF PEGINTERFERON ALFA-2B AND RIBAVIRIN THERAPY FOLLOWING MP-424 (TELAPREVIR) MONOTHERAPY FOR 24 WEEKS IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1B INFECTION

Journal of Hepatology ◽

10.1016/s0168-8278(10)60759-3 ◽

2010 ◽

Vol 52 ◽

pp. S295

Author(s):

O. Itaru

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Japanese Patients ◽

Virus Genotype ◽

Genotype 1B ◽

Chronic Hepatitis C Virus ◽

Peginterferon Alfa

Download Full-text

Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.13081 ◽

2015 ◽

Vol 41 (6) ◽

pp. 544-563 ◽

Cited By ~ 84

Author(s):

Z. M. Younossi ◽

H. Park ◽

S. Saab ◽

A. Ahmed ◽

D. Dieterich ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text